Search Results - "Nekeman, S." :: K.UTB vyhledávací portál

Loading…

The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands

by Van der Linden, N., Van Olst, S., Nekeman, S., Uyl‐de Groot, C.A.
Published in Diabetic medicine (01.04.2021)

Get full text

Journal Article

Loading…

EE4 Cost-Effectiveness of Andexanet Alfa Versus Prothrombin Complex Concentrate Is Likely for the Treatment of Factor Xa Inhibitor–Related Major Bleeds in the Netherlands

by Lewis, M., Wensvoort, N., Heeks, C., Codling, E., Gray, L., Nekeman, S., Van Haalen, H.
Published in Value in health (01.12.2023)

Get full text

Journal Article

Loading…

EE583 Cost-Effectiveness of Dapagliflozin in the Treatment of Chronic Symptomatic Heart Failure With Reduced Ejection Fraction in the Netherlands

by Kvamme, I, de Graaf, G, Nekeman, S, Gijsbers, S, Wester, V, Hoogendoorn, M
Published in Value in health (01.12.2022)

Get full text

Journal Article

Loading…

The effect of including ehealth in dietary interventions in patients with type 2 diabetes with obesity: A systematic review

by Geurts, K.A., Woodcock-Nekeman, S., Hummel, M., van Rossum, E.F., Berk, K.A.
Published in Clinical nutrition ESPEN (01.12.2023)

Get full text

Journal Article

Loading…

PDB81 - DAPAGLIFLOZIN IS COST-EFFECTIVE COMPARED TO DPP-4 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN THE NETHERLANDS

by Van Olst, S.P., Nekeman, S., van der Linden, N., Uyl-de Groot, C.A.
Published in Value in health (01.10.2018)

Get full text

Journal Article

Loading…

Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

by Miquel-Cases, A, Berk, A, Nekeman, S, Bastiaanse, M, Sellink, AA, Ruiz, S
Published in Value in health (01.10.2017)

Get full text

Journal Article

Loading…

PRS34 - Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

by Miquel-Cases, A, Berk, A, Nekeman, S, Bastiaanse, M, Sellink, AA, Ruiz, S
Published in Value in health (01.10.2017)

Get full text

Journal Article

The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands

EE4 Cost-Effectiveness of Andexanet Alfa Versus Prothrombin Complex Concentrate Is Likely for the Treatment of Factor Xa Inhibitor–Related Major Bleeds in the Netherlands

EE583 Cost-Effectiveness of Dapagliflozin in the Treatment of Chronic Symptomatic Heart Failure With Reduced Ejection Fraction in the Netherlands

The effect of including ehealth in dietary interventions in patients with type 2 diabetes with obesity: A systematic review

PDB81 - DAPAGLIFLOZIN IS COST-EFFECTIVE COMPARED TO DPP-4 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN THE NETHERLANDS

Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

PRS34 - Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database